Damon R Reed MD

Pediatric Hematology & Oncology•New York, NY

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Member, Memorial Hospital Memorial Sloan Kettering Cancer Center Solid Tumor Division Director, MSK Kids President, Connective Tissue Oncology Society Vice Chair, Bone Tumor Committee, COG

Request Appointment

160 East 53rd StreetNew York, NY 10022
Book by Phone+1(814) 247-0821

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 2005 - 2008
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2002 - 2005
Case Western Reserve University School of MedicineClass of 2002

Certifications & Licensure

FL State Medical License 2008 - 2026
NJ State Medical License 2025 - 2025
NY State Medical License 2023 - 2025
TN State Medical License 2005 - 2010
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
ACTIVE_NOT_RECRUITING
PHASE2
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01
Completed
Phase 2
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma Start of enrollment: 2016 Oct 25
ACTIVE_NOT_RECRUITING
PHASE2
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas Start of enrollment: 2018 Jun 04
Active, not recruiting
Phase 1
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma Start of enrollment: 2019 Oct 03
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma Start of enrollment: 2019 Sep 27
COMPLETED
PHASE1
Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board Start of enrollment: 2020 May 05
RECRUITING
Evolutionary Therapy for Rhabdomyosarcoma Start of enrollment: 2020 Dec 29
RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination.
Katie A Greenzang, Kathleen E Montgomery, Adam DuVall, Michael E Roth, Mark Krailo
Journal of the National Cancer Institute. 2025-03-31
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group.
Riaz Gillani, David S Shulman, Natalie J DelRocco, Kelly Klega, Ruxu Han
Medrxiv. 2025-01-20
2 citations
Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma.
John Michael Bryant, Matthew N Mills, Casey Liveringhouse, Russell Palm, Mihaela Druta
Radiotherapy and Oncology. 2025-01-01

Press Mentions

Salarius Pharmaceuticals to Expand Clinical Program to Target Additional Sarcomas in Ewing Sarcoma Phase 1/2 Clinical TrialJuly 29th, 2020
SP-2577 Granted Fast Track Designation by the FDA for Patients with Ewing SarcomaDecember 16th, 2019
Shortage of Critical Cancer Drug Forcing Some Children to Go WithoutOctober 21st, 2019
Join now to see all

Insurance Accepted

Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Illinois PPO
Blue Shield California HMO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Health Net California Large Group PPO
Health Net HMO - Employer Group
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Wellmark Alliance Select
Please verify your coverage with the provider's office directly when scheduling an appointment